names of glp 1 glp-1 ra drug List approved and pending medications Comparison of type 2 diabetes – Beyond GLP-1: the next wave

This matters as a new cornerstone therapy in type 2 diabetes (T2DM), glucagon-like peptide-1 receptor agonists (GLP-1), are entering broader use, necessitating a deeper dive into how this treatment interacts, directly or indirectly, with pathways influenced by sex hormones

see our "Who Is Not a Candidate" section below for details

However, as with any medication, side effects must be fully considered as part of the decision making process to initiate a medication

Research indicates that untreated gut imbalances may contribute to recurring digestive issues, increased infection risk, and even changes in immune function

Eli Lilly has applied for licensing in more than 40 countries for both type 2 diabetes and weight management, with plans for a rapid launch if its approved